Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01179308 · ClinicalTrials.gov registry record · NA

Regional Anesthesia and Lung Cancer Recurrence

A NA study, sponsored by The Cleveland Clinic.

Terminated
Registry status
NA
Development phase
67
Enrollment target

NCT01179308: Clinical Trial NA study, sponsored by The Cleveland Clinic.

NCT01179308 is a NA study that was terminated before completion, run by The Cleveland Clinic. The registered enrollment target is 67 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01179308, a NA study, was terminated before completion, sponsored by The Cleveland Clinic.

TERMINATED
Registry status
NA
Development phase
67 participants
Enrollment target

Study Summary

Test the effect of combined regiona/general anesthesia on lung cancer recurrence compared to general anesthesia alone.

Primary Outcome

The effect of regional versus general anesthesia on the primary outcome of disease-free survival (time to the earlier or recurrence or death from any cause)

Interventions

  • OTHER General-epidural anesthesia
  • OTHER Balanced general anesthesia and postoperative opioids

Trial Details

FieldValue
Enrollment Target 67 participants
Start Date 2010-08
Est. Completion 2015-08
Phase NA
The Cleveland Clinic

688 total trials

Why NCT01179308 stopped before completion

NCT01179308 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 67 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 2 interventions - of which General-epidural anesthesia is the first listed.

NCT01179308 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01179308 about?

NCT01179308 is a clinical study titled "Regional Anesthesia and Lung Cancer Recurrence". Test the effect of combined regiona/general anesthesia on lung cancer recurrence compared to general anesthesia alone.

What is the current status of trial NCT01179308?

This trial is currently terminated. It is a NA study. The enrollment target is 67 participants. The study started on 2010-08. Estimated completion is 2015-08.

What interventions are being tested in trial NCT01179308?

The interventions under investigation include: General-epidural anesthesia (OTHER), Balanced general anesthesia and postoperative opioids (OTHER).

Who is sponsoring clinical trial NCT01179308?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01179308's enrollment target sits among peer trials

67 1139th of 2000 higher than 862 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03213002 · 67 participants · Phase 1

    Oral Capecitabine and Temozolomide (CAPTEM) for Newly Diagnosed GBM

  • NCT04115163 · 67 participants · Phase 2

    Biologically Optimized Infusion Schedule of Gemcitabine and Nab-Paclitaxel for the Treatment of Metastatic Pancreatic Cancer

  • NCT04315324 · 67 participants · Phase 1

    Study to Test OBI-3424 in Patients With T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LBL)

  • NCT04532424 · 67 participants · NA

    Transcranial Magnetic Stimulation for Restricted and Repetitive Behavior in ASD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01179308, the US trial registry maintained by the National Library of Medicine. NCT01179308 (small enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.